Stocks
Cortexyme () EBITDA US GAAP (year values) |
|||||||||
| 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -10.5 | -11.5 | -39.2 | -78.9 | -90.3 | -83.5 | ||
| Changes by years, y/y, % | +9% | +242% | +101% | +14% | +71.1% | ||||
Cortexyme. EBITDA US GAAP, bln rub
Cortexyme. EBITDA US GAAP, changes, %
Cortexyme. EBITDA US GAAP, sum by quarters, bln rub
Cortexyme () EBITDA US GAAP (quarter values) |
||||||||
| 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -21.8 | -21.6 | -23.8 | -21.9 | -16.3 | -83.5 | |
| Changes by years, y/y, % | +20% | -1% | +27% | -5% | -25% | |||
| Changes by quarters, q/q, % | -5% | -1% | +10% | -8% | -26% | |||
